AstraZeneca-Daiichi’s breast cancer drug gets broader US nod
Anglo-Swedish AstraZeneca Plc., and Japan’s Daiichi Sankyo’s therapy to treat a certain form of breast cancer has been approved by the US drug.
Drugs
Health
Pharma